SS 33 - Advances in the Treatment of Brain Metastases

Presentations

• 02:15pm - 02:25pm ET

  Connectome-Informed Cognition-Sparing Stereotactic Brain Radiosurgery: Comparison of Cognitive Outcomes to Historical Controls

  Speaker: Andrew Puett, MD, PhD - UC San Diego, La Jolla
• 02:15pm - 03:30pm ET

  Advances in the Treatment of Brain Metastases

  Speaker: Aaron Simon, MD, PhD - UC Irvine Health, Orange
• 02:25pm - 02:35pm ET

  Upfront Local Therapy in Melanoma Brain Metastases Treated with Ipilimumab-Nivolumab: An International Multicenter Analysis of Immunotherapy-Naïve Patients

  Speaker: James Lee, BS - Memorial Sloan Kettering Cancer Center, Middletown Township
• 02:35pm - 02:45pm ET

  Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial

  Speaker: Chia-Lin Tseng, MD - Sunnybrook Health Sciences Centre, Toronto
• 02:45pm - 02:55pm ET

  Multi-Institutional Study of Stereotactic Radiosurgery in Patients with =15 Brain Metastases

  Speaker: Tina Vaziri, MD - Johns Hopkins Hospital, Baltimore
• 02:55pm - 03:05pm ET

  Clinicogenomic Risk Stratification Identifies Metastatic Breast Cancer Patients at High Risk for Symptomatic Brain Metastases

  Speaker: Luke Pike, MD, DPhil - Memorial Sloan Kettering Cancer Center, New York
• 03:05pm - 03:15pm ET

  Fractionated Stereotactic Radiotherapy for Limited Small Volume Brain Metastases: A Single-Center, Single Arm, Phase II Trial

  Speaker: Jia-Xuan Yang, MS - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing
• 03:15pm - 03:25pm ET

  Discussant

  Speaker: Minesh Mehta, MD, MB, ChB, FASTRO - Miami Cancer Institute- Baptist Health South Florida, Miami